Abeera Mohammad

479 total citations
7 papers, 114 citations indexed

About

Abeera Mohammad is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Abeera Mohammad has authored 7 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Abeera Mohammad's work include Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Abeera Mohammad is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Abeera Mohammad collaborates with scholars based in United Kingdom, Greece and Switzerland. Abeera Mohammad's co-authors include Stephen W. Duffy, Roberta Maroni, Jonathan P. Myles, Jo Caers, Florence Suzan, Xavier Leleu, Evangelos Terpos, Sally Wetten, Xavier Thomas and Barbara Gamberi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Medical Screening.

In The Last Decade

Abeera Mohammad

5 papers receiving 111 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abeera Mohammad United Kingdom 3 86 27 23 15 13 7 114
Omolara Fatiregun Nigeria 9 92 1.1× 20 0.7× 13 0.6× 20 1.3× 18 1.4× 24 158
Bertrand Camey Switzerland 6 100 1.2× 13 0.5× 14 0.6× 26 1.7× 21 1.6× 6 136
Ai‐Tram N. Bui United States 7 67 0.8× 23 0.9× 15 0.7× 14 0.9× 14 1.1× 15 139
Foziya Mohammed Hussien Ethiopia 7 92 1.1× 10 0.4× 11 0.5× 15 1.0× 21 1.6× 20 160
Claudia Uribe Colombia 7 81 0.9× 29 1.1× 20 0.9× 18 1.2× 15 1.2× 14 144
Simon Tso United Kingdom 6 40 0.5× 18 0.7× 10 0.4× 8 0.5× 10 0.8× 41 152
D. Paredes Spain 7 73 0.8× 16 0.6× 9 0.4× 10 0.7× 5 0.4× 24 129
Devon Spika United Kingdom 6 102 1.2× 25 0.9× 20 0.9× 23 1.5× 17 1.3× 8 152
Martín Ángel Argentina 7 70 0.8× 22 0.8× 10 0.4× 15 1.0× 8 0.6× 16 114
Rebecca Mottram United Kingdom 5 72 0.8× 7 0.3× 31 1.3× 21 1.4× 16 1.2× 10 126

Countries citing papers authored by Abeera Mohammad

Since Specialization
Citations

This map shows the geographic impact of Abeera Mohammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abeera Mohammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abeera Mohammad more than expected).

Fields of papers citing papers by Abeera Mohammad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abeera Mohammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abeera Mohammad. The network helps show where Abeera Mohammad may publish in the future.

Co-authorship network of co-authors of Abeera Mohammad

This figure shows the co-authorship network connecting the top 25 collaborators of Abeera Mohammad. A scholar is included among the top collaborators of Abeera Mohammad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abeera Mohammad. Abeera Mohammad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Terpos, Evangelos, Borhane Slama, Renato Zambello, et al.. (2020). Real-World Evidence of the Use of Carfilzomib Among Multiple Myeloma Patients with at Least One Prior Therapy across 10 European Countries and Israel. Blood. 136(Supplement 1). 38–39. 4 indexed citations
2.
3.
Caers, Jo, Xavier Leleu, Barbara Gamberi, et al.. (2019). Real-World Use of Carfilzomib Therapy Among Patients With Existing Cardiovascular Medical History: An Analysis of a Prospective Observational Study. Clinical Lymphoma Myeloma & Leukemia. 19(10). e281–e282.
4.
Terpos, Evangelos, Xavier Leleu, Barbara Gamberi, et al.. (2019). Real-World Evidence of the Use of Carfilzomib and Dexamethasone According to Age Subgroup: An Interim Analysis From a Prospective Observational Study. Clinical Lymphoma Myeloma & Leukemia. 19(10). e282–e283.
5.
6.
Terpos, Evangelos, Barbara Gamberi, Jo Caers, et al.. (2019). Real-world use of carfilzomib among multiple myeloma patients with at least one prior therapy.. Journal of Clinical Oncology. 37(15_suppl). e19515–e19515. 2 indexed citations
7.
Duffy, Stephen W., Jonathan P. Myles, Roberta Maroni, & Abeera Mohammad. (2016). Rapid review of evaluation of interventions to improve participation in cancer screening services. Journal of Medical Screening. 24(3). 127–145. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Omolara Fatiregun Breakdown of academic impact, for papers by Bertrand Camey Breakdown of academic impact, for papers by Ai‐Tram N. Bui Breakdown of academic impact, for papers by Foziya Mohammed Hussien Breakdown of academic impact, for papers by Claudia Uribe Breakdown of academic impact, for papers by Simon Tso Breakdown of academic impact, for papers by D. Paredes Breakdown of academic impact, for papers by Devon Spika Breakdown of academic impact, for papers by Martín Ángel Breakdown of academic impact, for papers by Rebecca Mottram
Rankless by CCL
2026